Top global biotech companies selection based on market cap 2023

This statistic depicts a selection of global top biotechnology companies based on market capitalization as of October 4, 2023. At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked first among such companies, with a market capitalization of over 300 billion U.S. dollars.Global biotechnologyAbbVie and Novo Nordisk are among the largest mostly biotech-oriented companies in the world. In October 2023, AbbVie, a company based in the U.S., had a market capitalization of 260 billion U.S. dollars, while Novo Nordisk had a market capitalization of some 300 billion U.S. dollars. As of 2020, there were 1,500 companies in the United States dedicated to biotechnology, while, in comparison, Germany had 753 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States. In the United States, medical biotechnology is a significant component of the whole biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated over 21 billion U.S. dollars in revenue globally in 2022. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 88.6 million acres of corn crops in the United States, only 6.2 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.

本统计数据显示，截至2023年10月4日，全球市值最高的生物技术公司选集。在此阶段，丹麦生物制药制造商诺和诺德位居首位，市值超过3000亿美元。全球生物技术公司中，美国艾伯维公司和丹麦诺和诺德是主要专注于生物技术的世界级大型企业。在2023年10月，美国艾伯维公司的市值为2600亿美元，而诺和诺德约为3000亿美元。至2020年，美国有1500家公司致力于生物技术领域，相比之下，德国有753家公司。位于旧金山地区和洛杉矶/橙县的生物技术公司在美国产生了最高的生物技术收入。在美国，医疗生物技术是整个生物技术产业的重要组成部分。研究、测试和医疗实验室的工作岗位显著增加。艾伯维公司研发的抗炎药物赫米拉在2022年全球创造了超过210亿美元的营收。由于新技术的创新和高质量医疗技术的需求，生物制药市场预计将继续增长。生物技术也广泛应用于农业领域。美国生物技术作物占全球总量的半数以上。在美国，共计8860万英亩的玉米种植面积中，仅有620万英亩被视为非生物技术田地。生物技术亦拓展至工业领域，为纳米技术、酶和生物燃料等领域提供创新动力。